Discover 191 paid clinical trials in North Dakota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
North Dakota offers many paid research opportunities statewide, giving healthy volunteers and individuals with specific health needs access to a wide range of clinical studies. Key cities like Fargo, Bismarck, and Grand Forks are home to research centers actively recruiting participants, offering access to the latest treatments and medical advancements.
Filter
1
Filter results
Results: 191
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Location: Scarborough ME, The Bronx NY, Albany NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT07022678
Phase 3, Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Westerly RI, Worcester MA, Waterford CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061964
Phase 2, Recruiting
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: New York NY, Sweetwater FL, Sanford FL, Tampa FL,
Sponsor: Incyte Corporation
Sex: All
Age: 12 - 70+
Code: NCT07049575
Phase 1, Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
E-Mindfulness Approaches for Living After Breast Cancer
for
Breast Cancer, Depression
Location: Gloucester MA, Beverly MA, Peabody MA, Boston MA,
Sponsor: NRG Oncology
Sex: All
Age: 18 - 50
Code: NCT06748222
Phase 3, Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for
Prostate Cancer (Adenocarcinoma)
Location: Saint John, Providence RI, Saint Johnsbury VT,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06592924
Phase 3, Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
for
Malignant Neoplasm
Location: Boston MA, New Haven CT, Valhalla NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT06941272
Phase 1, Phase 2, Recruiting
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for
Moderate Aortic Valve Stenosis
Location: Boston MA, Quebec, The Bronx NY, Albany NY, Montreal,
Sponsor: Kardigan, Inc.
Sex: All
Age: 50+
Code: NCT07001800
Phase 2, Phase 3, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: St. John's, Bangor ME, Scarborough ME, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Guilford CT, New Haven CT, Derby CT, Burlington VT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase 2, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: St. John's, Westbrook ME, Boston MA, Quebec, Sherbrooke,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase 3, Recruiting
Integrated Cancer Repository for Cancer Research
for
Pancreatic Cancer, Thyroid Cancer, Lung Cancer,
Location: Manchester CT, Holyoke MA, Glens Falls NY, Utica NY,
Sponsor: University of Nebraska
Sex: All
Age: 19 - 70+
Code: NCT02012699
Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase 2, Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase 2, Phase 3, Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Damariscotta ME, Bath ME, Augusta ME, Brunswick ME,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase 3, Recruiting
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
for
Type 1 Diabetes, Celiac Disease
Location: Bemidji MN, Fargo ND, Sioux Falls SD, Bismarck ND